Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
MTH1 Antibody (AT3B3) - BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
$337.00 - $482.50
Specifications
Antigen | MTH1 |
---|---|
Clone | AT3B3 |
Concentration | 1 mg/mL |
Dilution | Western Blot 1:100-1:2000, ELISA 1:100-1:2000, Immunocytochemistry/Immunofluorescence 1:10-1:500 |
Applications | Western Blot, ELISA, Immunocytochemistry, Immunofluorescence |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
NBP26116050
|
Novus Biologicals
NBP26116050UL |
50 μL |
Each for $337.00
|
|
|||||
NB261160100
|
Novus Biologicals
NBP261160100UL |
100 μL |
Each for $482.50
|
|
|||||
Description
MTH1 Monoclonal specifically detects MTH1 in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunocytochemistry/Immunofluorescence.Specifications
MTH1 | |
1 mg/mL | |
Western Blot, ELISA, Immunocytochemistry, Immunofluorescence | |
Unconjugated | |
Mouse | |
Human | |
8-oxo-7,8-dihydrodeoxyguanosine triphosphatase, EC 3.6.1.-, MTH1Nucleoside diphosphate-linked moiety X motif 1, mutT human homolog 1,8-oxo-dGTPase, nucleoside diphosphate-linked moiety X-type motif 17,8-dihydro-8-oxoguanine triphosphatase, nudix (nucleoside diphosphate linked moiety X)-type motif 1,8-oxo-7,8-dihydroguanosine triphosphatase, Nudix motif 1 | |
NUDT1 | |
IgG1 κ | |
Protein A or G purified |
AT3B3 | |
Western Blot 1:100-1:2000, ELISA 1:100-1:2000, Immunocytochemistry/Immunofluorescence 1:10-1:500 | |
Monoclonal | |
Purified | |
Base Excision Repair, Cancer, Chromatin Research, DNA Repair, Modulation of DNA Pools, Stem Cell Markers | |
PBS (pH7.4) w/ 10% glycerol with 0.02% Sodium Azide | |
4521 | |
Recombinant human NUDT1 (1-156aa) purified from E. coli | |
Primary | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Spot an opportunity for improvement?
Provide Content Correction
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title